Could a common supplement tame multiple sclerosis?
NCT ID NCT07263607
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding taurine, a natural amino acid, to standard multiple sclerosis (MS) medications can improve outcomes. About 80 adults with relapsing-remitting MS will either continue their usual drugs or add daily taurine for 24 months. Researchers will track brain lesions, relapses, disability, and gut health to see if taurine offers extra protection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- taurine
- What this could lead to
- If it works, adding taurine to standard MS therapy could help reduce brain damage, relapses, and slow disability progression.
- What could go wrong
- This is a small, early-phase trial with only 80 people. Taurine may show no added benefit over standard drugs, and results may not apply to all MS patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS (MS) RELAPSING REMITTING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain scans to reveal if new MS drug quietly calms inflammation
- Could a lighter MS treatment keep the disease at bay?
- A motorized hip brace may help MS patients walk better — small study puts it to the test
- Ear stimulation may help repair nerve damage in multiple sclerosis
- Could a gentle zapping of the brain ease MS fatigue and brain fog?
- Gentle exercise with cuffs may boost muscle in MS patients